Elevated CCL20 production and its receptor CCR6 have been related to the progression of a variety of human cancers, including liver cancer, colorectal cancer, breast cancer, and kidney cancer, and also indirectly modulates the function of immune cells in response to inflammatory diseases [59,60]. This evidence concerns the gene CCR6 and liver cancer.